Showing results filtered by:
11 Results
Effective writing is an important skill that will benefit a scientist throughout every stage of their career. Postdoctoral fellow Sivarchana Boada, Ph.D., highlights the key components of successful academic and professional writing from January’s three-part skill blitz series.
Published: January 31, 2023
NIAID requires your human subjects research plans to include women, minorities, and participants of all ages unless you can justify their exclusion.
Last Reviewed: January 24, 2022
NIAID Biodefense Research Agenda for CDC Category A Agents - 2006 Progress Report
https://www.niaid.nih.gov/sites/default/files/cata_2006.pdf
Last Reviewed: August 6, 2019
Food Allergy Summary for Patients, Families, and Caregivers
https://www.niaid.nih.gov/sites/default/files/faguidelinespatient.pdf
Last Reviewed: July 9, 2019
NIAID Biodefense Research Agenda for CDC Category A Agents - Progress Report August 2003
https://www.niaid.nih.gov/sites/default/files/category_a_progress_report.pdf
Last Reviewed: August 6, 2019
Sample Application (K08): Al-Adra
https://www.niaid.nih.gov/sites/default/files/1-k08-ai155816-01a1-aladra-application-508.pdf
Last Reviewed: September 13, 2024
Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020
https://www.niaid.nih.gov/sites/default/files/ORWH-Biennial-Report2019-20.pdf
Last Reviewed: March 8, 2022
Sample Application (R44): Yingru Liu
https://www.niaid.nih.gov/sites/default/files/R44-Liu-Application.pdf
Last Reviewed: November 25, 2022
NIH Consolidated Opening Statement Senate LHHS FY 2019 Hearing
https://www.niaid.nih.gov/sites/default/files/NIH-Consolidated-Opening-Statement-Senate-LHHS-FY-2019-Hearing.pdf
Last Reviewed: August 16, 2018
Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002
https://www.niaid.nih.gov/sites/default/files/jordan20_2002.pdf
Last Reviewed: December 31, 2002
The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and
Last Reviewed: February 5, 2024